Nonprofit Working to Block Drug Imports Has Ties to Pharma Lobby

Re:Nonprofit Working to Block Drug Imports Has Ties to Pharm... by maxerickson on Tuesday April 18, 2017 @12:34PM (#14140244)

Mylan has a patent on some minor improvement to Epipens. So it isn't just the FDA, they pushed generics off the market.

Mylan flat out admitted that costs aren't any more than $150 per pen when they launched a generic version of their own branded product. Everything above that is clearly them working to get as much price differentiation as possible.

[ Parent | on HN ]

Re:Nonprofit Working to Block Drug Imports Has Ties to Pharm... by pc86 on Tuesday April 18, 2017 @12:46PM (#14140390)

So why not sell Epipens without those minor, patented improvements for $20? Surely if there's profit to be made another provider would come in and destroy the $700 marginally better Epipen market.

[ Parent | on HN ]

Re:Nonprofit Working to Block Drug Imports Has Ties to Pharm... by maxerickson on Tuesday April 18, 2017 @01:00PM (#14140519)

I don't know why there weren't more competitors. Apparently part of it is that it is difficult to get right. Adrenaclick generics have been on the market much of that time for $150 or less.

One thing though, they would be epinephrine auto injectors, not Epipens, that's one of the things the patent did, it made it so that a prescription for Epipen could only be filled with Mylan's product.

[ Parent | on HN ]